Yahoo Finance Trapped under rubble, quake survivor told, "stay calm"
A man tries to soothe a person who is trapped under rubble in the rural village of Capodacqua after a deadly 6.2 magnitude hits central Italy. Rough Cut - Subtitled (no reporter narration).
A man tries to soothe a person who is trapped under rubble in the rural village of Capodacqua after a deadly 6.2 magnitude hits central Italy. Rough Cut - Subtitled (no reporter narration).
Stock Market Today: The Dow Jones fell Wednesday as Boeing and Tesla jumped on earnings. Meta earnings are due late.
The outgoing chief executive of top semiconductor equipment supplier ASML said on Wednesday that the U.S. government will prevent the company from servicing some machines it has previously sold to Chinese customers in some cases. Such restrictions "will not have a significant effect on the 2025 to 2030 financials, because it will be a limited number" of Chinese plants that are affected, Peter Wennink said. ASML, the largest maker of equipment used to manufacture computer chips, has faced a series of restrictions and licensing requirements from the U.S. and Dutch governments in selling its more advanced equipment lines to Chinese customers.
Shares of AT&T (T) are trading higher at Wednesday's open after the company revealed it added more wireless phone subscribers than expected in the first quarter. The telecommunications giant added 349,000 new postpaid phone connections, outperforming analysts' expectations of 304,000 additions. Yahoo Finance's Seana Smith and Brad Smith break down the details, providing insights into AT&T's growth despite increased competition. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith
Vicor Corporation (NASDAQ:VICR) Q1 2024 Earnings Call Transcript April 23, 2024 Vicor Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone and thank you for standing by. Welcome to the Q1 2024 Vicor Earnings Conference Call. [Operator […]
REDWOOD CITY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the first presentation of clinical data for CHS-114, a highly selective cytolytic anti-CCR8 antibody, at the upcoming ASCO Annual Meeting, which will be held from May 31 to June 4, 2024, at McCormick Place in Chicago. Presentation Details Abstract: 2664Title: Preliminary Results of a Phase 1, First-in-human, Dose Escalation Study of the Anti-CCR8 Cytolytic Antibody, CHS-114
Reggie Bush has been reinstated as the 2005 Heisman Trophy winner more than a decade after Southern California returned the award following an NCAA investigation that found he received what were impermissible benefits during his time with the Trojans, the Heisman Trust announced Wednesday. “We are thrilled to welcome Reggie Bush back to the Heisman family in recognition of his collegiate accomplishments,” said Michael Comerford, president of The Heisman Trophy Trust.
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced today that it will present an oral abstract and poster at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31 – June 4, 2024 in Chicago, IL. The presentations will highlight the Company’s Phase 1 trials of its lead interleukin 2 (IL-2)-
The US Senate has passed £49bn in military aid for Ukraine which can be delivered ‘within days’
MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- ML Tech, a leading digital asset wealth management platform, in collaboration with ARB Fund Management LLC, announced that its Digital Asset Market Neutral Opportunities Fund (“the Fund”) reached an important milestone: six months of live trading with an auditable track record. The Fund is Cayman Island based and available to global investors. The Digital Asset Market Neutral Opportunities Fund consists of delta-neutral strategies such as funding rate ar
Fred A. Schulz CareSource announced the appointment of Fred A. Schulz to Chief Operating Officer (COO). DAYTON, Ohio, April 24, 2024 (GLOBE NEWSWIRE) -- CareSource, a nationally recognized nonprofit managed care organization, announced today the appointment of Fred A. Schulz to Chief Operating Officer (COO). He is a member of the company’s executive leadership team and reports to CareSource President and CEO Erhardt Preitauer. In this role, Schulz will leverage his vast experience in government
BoldDesk and Bold BI include new AI-powered features RESEARCH TRIANGLE PARK, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Syncfusion, Inc., the enterprise technology provider of choice, today announced several updates to the company’s Bold line of enterprise solutions, including the release of artificial intelligence (AI)-powered features in Bold BI, the company’s dashboarding and analytics platform, and BoldDesk, its customer service software solution. Additionally, Syncfusion’s reporting platform,
LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that the abstract for longer-term follow-up and additional data analysis from the pivotal Phase 2 FELIX study of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult B-cell Acute Lymphoblastic Leukemia (ALL) was selected for an oral presentation at the 2024 American Society of Clinica
Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data selected for rapid oral session presentation MCLA-145 as monotherapy or in combination with pembrolizumab in solid tumors initial interim clinical data selected for rapid oral session presentation MCLA-129 in NSCLC with c-MET exon 14 skipping mutations initial interim clinical data selected for poster presentation UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (N
Immunocore announces upcoming presentation and posters at ASCO 2024 Phase 1 expansion data in immune checkpoints pre-treated cutaneous melanoma for brenetafusp (IMC-F106C targeting PRAME) to be presented during oral abstract session (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 24 April 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to ra
SOUTH SAN FRANCISCO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced the acceptance of two abstracts for poster presentation at the American Society of Cancer Oncology (“ASCO”), which will be held in Chicago from May 31-June 4, 2024. Session titles and information for the two abstracts are listed below and are now
Polish explosives-maker Nitro-Chem said on Wednesday it had signed deal to supply TNT (trinitrotoluene) to U.S.-based Paramount Enterprises International (PEI) for bombs and ammunitions. On Tuesday, the U.S. Senate passed a $95 billion bill to aid Ukraine and Israel, among others, and replenish U.S. stocks of weapons shipped abroad. "The agreement ... assumes regular deliveries of TNT to the United States, which will be used to implement American government weapons programs for 2026," Nitro-Chem, a subsidiary of Poland's state-owned PGZ group, said in a press release.
New York City, NY , April 24, 2024 (GLOBE NEWSWIRE) -- $COMEW is set to revolutionize the crypto space with its debut on RAYDIUM DEX at 13:00 UTC on April 24, 2024. Promising no tax trading and bolstered by significant partnerships, this launch is anticipated to make waves across various top-tier and second-tier cryptocurrency exchanges. The cryptocurrency community is buzzing with excitement as $COMEW prepares to go live on RAYDIUM DEX, introducing a groundbreaking opportunity for tax-free trad
CAPE TOWN, South Africa and NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- TransPerfect, the world's largest provider of language and AI solutions for global business, today announced that it has acquired South Africa-based Content Lab, a provider of audiovisual localization services for media and entertainment clients. Financial terms of the transaction were not disclosed. With its world-class recording studios and production departments, Content Lab’s services include dubbing and voiceover, subt
Together the three entities will collaborate to develop interoperable digital identities that work across the Internet and Web3Las Vegas, Nevada, April 24, 2024 (GLOBE NEWSWIRE) -- MAKE, a blockchain technology innovation firm, with the support of the Casper Association, have announced an exclusive partnership with D3 Global, a next-generation domain name company developing interoperable digital identities, to apply for and obtain the .cspr Top-Level Domain (TLD) during ICANN’s upcoming applicat
BERKELEY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstracts have been accepted for poster presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 31-June 4, 2024 in Chicago, Illinois. The ANTLER poster will provide initial dose expansion data. Details of the poster presentation are as follows: Title: A CRI